Trial NCT01678820

View at ClinicalTrials.gov 
Org. Study IDs: 0431D-266

Last trial update was posted on 2018-08-24

MeSH Interventions

Glimepiride Metformin Simvastatin Sitagliptin Phosphate

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions

Type 2 Diabetes Mellitus

Stopping Reasons

Merck terminated the study for business reasons in November 2013.

Limitations And Caveats

Study was terminated for business reasons in November 2013.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID